Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China flag China · Delayed Price · Currency is CNY
15.45
+0.20 (1.31%)
Feb 3, 2026, 2:55 PM CST

SHE:300601 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,123432.841,1961,0183,550882.69
Short-Term Investments
-2,174463.34531.58725.57-
Trading Asset Securities
527.4-100.02440.83-2,155
Cash & Short-Term Investments
1,6512,6071,7591,9904,2753,038
Cash Growth
431.20%48.21%-11.61%-53.45%40.73%501.29%
Accounts Receivable
2,8262,7872,7882,2931,8581,613
Other Receivables
7.2810.548.911.3814.2559.09
Receivables
2,8342,7982,7972,3051,8721,672
Inventory
630.24782.77772.85727.81,058436.55
Other Current Assets
1,09855.0967.51152.34135.14197.71
Total Current Assets
6,2136,2425,3965,1757,3415,345
Property, Plant & Equipment
5,0155,2255,7165,1764,1162,279
Long-Term Investments
0-311.68302.38105.64101.71
Other Intangible Assets
475.61436.66433.45357.98346.04294.36
Long-Term Deferred Tax Assets
744.19697.63630.32708.32558.6702.05
Long-Term Deferred Charges
218.21268.26172.47195.95489.6195.57
Other Long-Term Assets
1,4691,6932,4251,8711,192667.18
Total Assets
14,13414,56415,08513,78614,1499,585
Accounts Payable
709.6847.83882.48434.13708.2167.36
Accrued Expenses
30.181,3581,5951,330807.26798.67
Short-Term Debt
14.434.160.04170.07777.5311.32
Current Portion of Long-Term Debt
7.59202.9532.32103.6122.612.07
Current Income Taxes Payable
17.136.32--65.64-
Current Unearned Revenue
42.2419.2828.7631.2394.5114.95
Other Current Liabilities
1,479178.17152.69270.96142.39751.57
Total Current Liabilities
2,3002,6472,7512,3402,6181,756
Long-Term Debt
1,8491,7862,3722,0161,93867.8
Long-Term Unearned Revenue
234.11247.82328.7383.1349.54278.5
Long-Term Deferred Tax Liabilities
31.234.5226.8926.0841.4718.83
Other Long-Term Liabilities
109.17186.7264.5136.3335.13-
Total Liabilities
4,5244,9035,5444,8014,9822,121
Common Stock
1,1171,1171,1171,120687.09684.93
Additional Paid-In Capital
5,5125,5115,3695,4905,3575,265
Retained Earnings
2,4712,5232,5441,8842,6121,555
Treasury Stock
----20-0.55-41.55
Comprehensive Income & Other
510.86510.95511.1511.14511.3-
Total Common Equity
9,6119,6619,5428,9859,1677,463
Minority Interest
-0.07-0.1----
Shareholders' Equity
9,6119,6619,5428,9859,1677,463
Total Liabilities & Equity
14,13414,56415,08513,78614,1499,585
Total Debt
1,8712,0242,4652,2892,73891.19
Net Cash (Debt)
-220.37583.32-705.64-299.341,5372,947
Net Cash Growth
-----47.84%1082.44%
Net Cash Per Share
-0.180.52-0.63-0.271.382.74
Filing Date Shares Outstanding
1,1171,1171,1171,1201,1201,096
Total Common Shares Outstanding
1,1171,1171,1171,1201,0991,096
Working Capital
3,9123,5952,6452,8354,7233,589
Book Value Per Share
8.608.658.548.028.346.81
Tangible Book Value
9,1359,2249,1088,6278,8217,169
Tangible Book Value Per Share
8.188.268.157.708.026.54
Buildings
-2,7802,7181,037939.37859.63
Machinery
-2,8401,8531,6711,682731.24
Construction In Progress
-990.282,2813,4632,3201,136
Source: S&P Global Market Intelligence. Standard template. Financial Sources.